Fact CheckerSign in

NCT07151274Recruiting

Impact of Ehlers-Danlos Syndrome on Gynaecological Health

Impact of Ehlers-Danlos Syndrome on Gynaecological Health: Focus on the Prevalence of Dysmenorrhoea

Source: ClinicalTrials.gov · Last updated 10 Jun 2026

Brief summary (registry, in English)

Dysmenorrhea is a common problem in gynaecology, significantly impacting patients' quality of life. Ehlers-Danlos syndrome (EDS) is associated with joint hypermobility, tissue fragility and chronic pain. Some studies suggest an increased prevalence of gynaecological disorders, including dysmenorrhea, in patients with EDS. However, data remain limited and few studies have compared the intensity and characteristics of dysmenorrhea in women with EDS. There is also little data on the prevalence of other gynaecological conditions in women with EDS. This study therefore aims to compare the severity of dysmenorrhea in patients with EDS and a control group in order to better characterise the gynaecological impact of EDS. It will also compare the prevalence of other gynaecological conditions between women with EDS and women without EDS.

Status (registry)
Recruiting
Study type
Observational
Enrollment
156 (estimated)
First submitted
21 Aug 2025
Start date
7 Jul 2025
Primary completion date
1 Jul 2026
Lead sponsor
University Hospital, Rouen
NCT number
NCT07151274

What you commit to

  • Study type: Observational
  • Planned participants: 156
  • From 7 Jul 2025 to the primary completion date, 1 Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Age

  • Minors (\< 18 years old).

Other

  • Menopausal women
  • People who do not understand French well enough to complete the questionnaire.
  • Uncertain diagnosis of EDS (exclusion of participants who suspect EDS but without medical confirmation).

Who the study is looking for

  • Women aged 18 or over.
  • Willing to participate voluntarily in the study via an online questionnaire.
  • Of childbearing age.
  • Reporting a diagnosis of EDS (all types) or not having EDS (control group) and being part of a database of healthy volunteers.

Age in the registry: 18 years to 50 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
CHU de Rouen
Coordinator of this site? Confirm its status
RouenFranceRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.

Impact of Ehlers-Danlos Syndrome on Gynaecological Health (NCT07151274) – Frontlight Research